1
/
of
0
FDA Drug Approval, A205894, CYCLOSPORINE
FDA Drug Approval, A205894, CYCLOSPORINE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 205894
Company: MYLAN
Drug Name: CYCLOSPORINE
Active Ingredients: CYCLOSPORINE
Strength: 0.05%
Dosage Form/Route: EMULSION;OPHTHALMIC
Action Date: 02/02/2022
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: MYLAN
Drug Name: CYCLOSPORINE
Active Ingredients: CYCLOSPORINE
Strength: 0.05%
Dosage Form/Route: EMULSION;OPHTHALMIC
Action Date: 02/02/2022
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details